BioMarker Strategies, LLC - Product Pipeline Analysis, 2013 Update: New Research Report Available at Fast Market Research
BioMarker Strategies, LLC (BioMarker Strategies) is a tissue-based cancer diagnostics company. The company's product SnapPath, a novel automated tumor biopsy processing and testing system, is used to test and analyze a patient's live solid tumor sample at the point of biopsy. Its SnapPath platform enables the development of PathMap profiles which help guide targeted drug treatment selection, including drug combinations. BioMarker Strategies SnapPath units are being utilized in human clinical and preclinical studies for advanced melanoma and other solid tumors....
View full press release